Experimental cancer drug trial halted early

NCT ID NCT04242147

First seen Oct 31, 2025 · Last updated Apr 25, 2026 · Updated 25 times

Summary

This early-stage study tested a new drug called KD033 in 45 adults with advanced solid tumors that had spread. The main goal was to check safety and find the right dose, not to cure the cancer. The study was stopped early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fox Chase Cancer Center - 333 Cottman Avenue - Site 141

    Philadelphia, Pennsylvania, 19111, United States

  • Moffitt Cancer Center - Site 102

    Tampa, Florida, 33612, United States

  • Roswell Park Cancer Institute - 665 Elm St - Site 062

    Buffalo, New York, 14263, United States

  • UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042

    Santa Monica, California, 90404, United States

  • University of Pittsburgh Medical Center - Hillman Cancer Center - 5150 Centre Avenue, Suite 301 - Site 132

    Pittsburgh, Pennsylvania, 15232, United States

Conditions

Explore the condition pages connected to this study.